in november 2018 , 3 YEARS AGO NOW:
XORTX received a response from the FDA regarding the recently submitted ODD application submitted in September 2018 which clarified the additional information needed to obtain ODD for the use of XRx-008 as a treatment for ADPKD. Supplemental information will be filed with the FDA in 2019 to continue the process of obtaining ODD status for XRx-008
As of today : NO NEWS , NOTHING.
And when Madoff is going on a promotionnal show , not a f...ck ...ing single interviewer ask him this critical question: Where are you with the FDA and when we'll hear about it????